Live feed
Filing
SC 13D/A
SC 13D/A0001104659-24-111544·Avalon Ventures XI, L.P.
Schedule 13D ownership disclosure
Janux Therapeutics Inc
Security class unavailable · CUSIP: 47103J105
Event date: 2024-10-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,828,127
- Percent of class
- 3.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-111544
- Form type
- SC 13D/A
- Filer
- Avalon Ventures XI, L.P.
- CIK
- CIK 1652901
- Filed
- Oct 25, 2024
- Reporting period
- Oct 23, 2024
- Description
- Schedule 13D beneficial ownership